Project Dulce for Filipino-Americans With Type 2 Diabetes
NCT05378620
Summary
This study aims to culturally adapt an existing American Diabetes Association (ADA)-recognized diabetes self-management and support or DSMES (Diabetes Self Management Education Support) program (Project Dulce) and integrate an evidence-based text messaging program (Dulce Digital) for implementation in Filipino Americans (FAs) with type 2 diabetes mellitus (T2DM). Cultural adaptations aims to facilitate and enhance patient centered approaches and increase participant engagement by addressing barriers to DSMES unique to FAs, such as linguistic challenges, health literacy and numeracy, cultural beliefs and values, and technology access and use. In addition, this study aims to examine the effectiveness of the culturally and digitally adapted Project Dulce + Dulce Digital in improving diabetes knowledge, belief, attitudes, hemoglobin A1C (glycosylated hemoglobin), and self-management behaviors at baseline to 3 months and 6 months. The unprecedented increase of T2DM prevalence among racial and ethnic minority populations including FAs in recent decades demands for effective strategies to meet the needs in DSMES in this population. The outcomes of the current study will demonstrate that the culturally adapted Project Dulce and integration of Dulce Digital is effective in addressing the needs FAs, an underserved racial and ethnic minority group in high need of culturally appropriate DSMES.
Eligibility
Inclusion Criteria: * Self-identified Filipino * Diagnosed with T2DM * Registered at Scripps Health or San Ysidro Health (or willing to register) * HbA1c ≥7.5% and/or systolic blood pressure ≥ 140, and/or LDL-C ≥ 100 mg/dL within 90 days * Able to speak, read, write, and comprehend in English and Tagalog * Have access to a cell phone that can receive/send text messages throughout the study Exclusion Criteria: * Severe illness precluding frequent visits to clinic * Liver function tests (ALT and AST) \> 3 times the upper limit of normal * Body mass index ≤ 23 kg/cm * History of malignancy, except subjects who have been disease-free for \>years, or whose only malignancy has been basal or squamous cell skin carcinoma * Creatinine \>3.5 * History of drug or alcohol abuse within 12 months prior to enrollment * Not a permanent resident in the area * Current enrollee in Project Dulce * Blood donation of one pint or more within the past 30 days, or plasma donation within 7 days prior to screening * Anemia * Type 1 or gestational diabetes * Pregnant * Are currently participating in another diabetes-related study
Conditions2
Locations2 sites
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05378620